Oruka Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2010 | — | $6.8M | $7.0M |
| FY2011 | — | $5.7M | $5.9M |
| FY2012 | — | $2.9M | $2.9M |
| FY2013 | — | $15.6M | $16.8M |
| FY2014 | — | $14.7M | $15.4M |
| FY2015 | — | $38.1M | $38.8M |
| FY2016 | — | $22.2M | $7.4M |
| FY2017 | — | $10.3M | $8.7M |
| FY2018 | — | $6.0M | $6.6M |
| FY2019 | — | $7.6M | $8.4M |